Autism clinical trials at UCSF

2 in progress, 1 open to eligible people

Autism is a brain difference that affects social skills and daily routines. UCSF is testing external nerve stimulation in children who have both autism and ADHD. The trial records attention levels and checks safety over time.

Showing trials for

  • External Trigeminal Nerve Stimulation for Children With ASD + ADHD to Reduce Elevated Symptoms

    open to eligible people ages 7-14

    The goal of this clinical trial is to learn if external trigeminal nerve stimulation (eTNS) works to treat ADHD symptoms in children on the autism spectrum (ASD). It will also learn about the efficacy and tolerability of the eTNS device. The main questions it aims to answer are: - Does eTNS reduce ADHD symptoms? - Does eTNS improve core and associated features of ASD? Participation spans 8-12 weeks and includes: - 4-5 in-person visits - 4 brief virtual check-ins - Nightly use of the eTNS device with a small sticky patch applied to child's forehead - Randomized assignment (those who start with the sham device may try the active device later)

    San Francisco, California

  • CM-AT for the Treatment of Children With Autism

    Sorry, in progress, not accepting new patients

    This is a Phase III, open label extension study evaluating the continued safety and efficacy of CM-AT in pediatric patients with autism with all levels of fecal chymotrypsin.

    San Francisco, California and other locations

Our lead scientists for Autism research studies include .

Last updated: